Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Study explores role of AI automation in psychotherapy practice

6

Apr 2026

Study explores role of AI automation in psychotherapy practice

Psychotherapy has always been a deeply human endeavor: a patient talking, a therapist listening and responding, and healing happening through words. But with the rapid rise of conversational artificial intelligence, particularly large language models (LLMs), that paradigm is shifting fast.

New blood biomarker improves cancer risk detection in people with Lynch Syndrome

6

Apr 2026

New blood biomarker improves cancer risk detection in people with Lynch Syndrome

Researchers at The University of Texas MD Anderson Cancer Center have discovered a new blood-based biomarker that can help identify and characterize asymptomatic people with Lynch Syndrome (LS) who are more susceptible to developing cancer based on early immune detection signatures, allowing clinicians to stratify patients based on their personal risk level.

Novel screening method boosts early diagnosis of leprosy

6

Apr 2026

Novel screening method boosts early diagnosis of leprosy

A new blood test combined with a standardized questionnaire and artificial intelligence may transform the way leprosy is diagnosed in Brazil. Researchers at the University of São Paulo (USP) tested the new test in Brazil using blood samples collected during a COVID-19 population survey.

Researchers track how youth drinking deaths changed worldwide over 31 years

6

Apr 2026

Researchers track how youth drinking deaths changed worldwide over 31 years

A global analysis of GBD 2021 data found that youth drinking contributed to 417,198 deaths across 194 WHO member countries and territories between 1990 and 2021, with deaths declining from 13,346 to 10,563 over the period. Boys and young men bore a far higher burden, and most alcohol-attributable deaths were linked to transport injuries, interpersonal violence, and self-harm, with marked disparities across SDI levels and countries.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.